United States · Bill · HR
H.R. 4455 (116th)
BIOSIM Act
Introduced
20 September 2019
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 20 September 2019
Introduced in House (PDF)
Introduced in House · EN · 20 September 2019
Introduced in House
summary · EN · 20 September 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/4455
- Open data entity: https://api.congress.gov/v3/bill/116/hr/4455